Genedrive Share News (GDR)

Genedrive Information

Buy GDR Shares
Add GDR to Watchlist
Add GDR to Alert

Share Price Information for Genedrive (GDR)

Share Price is delayed by 15 minutes

Get Live Data

Share Price: 1.75

Bid: 1.70

Ask: 1.80

Change: 0.00 (0.00%)

Spread: 0.10 (5.882%)

Open: 0.00

High: 0.00

Low: 0.00

Prev. Close: 1.675

Last checked at -

UK shareholder meetings calendar - next 7 days

Thu, 22nd Dec 2022 15:44

Friday 23 December
Plexus Holdings PLC	AGM
Wildcat Petroleum PLC	AGM
Monday 26 December
no events scheduled
Tuesday 27 December
Zambeef Products PLC	AGM
Wednesday 28 December
Evrima PLC	AGM
Greencare Capital PLC	GM re proposed name change
Lift Global Ventures PLC	GM re proposed expansion within the energy sector
Thursday 29 December
Amte Power PLC	AGM
ADVFN PLC	AGM
Genedrive PLC	AGM
Hotel Chocolat Group PLC	AGM
Lekoil Ltd	EGM re proposed settlement and name change
Online Blockchain PLC	AGM
PetroNeft Resources PLC	AGM
SkinBioTherapeutics PLC	AGM

Copyright 2022 Alliance News Ltd. All Rights Reserved.

More News

24 Apr 2020 14:47

Inspiration Healthcare Signs Distribution Agreement With Genedrive

20 Apr 2020 11:40

Genedrive To Collaborate On Rapidly Manufactured Covid-19 Test

25 Mar 2020 14:57

Genedrive Shares Soar As It Says It Will Develop SARS-COV-2 Tests

4 Feb 2020 12:22

Genedrive Shares Plunge 45% As Loss Widens On Shipping Order Delays

28 Jan 2020 16:06

UK Earnings, Trading Statements Calendar - Next 7 Days

3 Dec 2019 10:10

Genedrive Antibiotic Induced Hearing Loss Test Kit Shows High Accuracy

3 Dec 2019 09:39

Genedrive upbeat on latest results from RNR1 kit testing

(Sharecast News) - Near-patient molecular diagnostics company Genedrive announced on Tuesday that in its case-control clinical validation, the antibiotic-induced hearing loss assay - the 'Genedrive MT-RNR1 ID' kit - achieved a diagnostic sensitivity of 100% and specificity of 100% on a cohort of 303 samples.

18 Nov 2019 16:00

Genedrive infant hearing loss test gets CE mark

(Sharecast News) - Molecular diagnostics company Genedrive announced on Monday that its antibiotic-induced hearing loss test, the 'Genedrive MT-RNR1 ID' kit, has obtained CE marking.

18 Nov 2019 11:15

Genedrive's Antibiotic Induced Hearing Loss Assay Receives CE Marking

7 Oct 2019 11:59

NHS Ethics Approval Granted For Genedrive MT-RNR1 Screening Test Trial

3 Oct 2019 11:00

Genedrive Outlook Positive As Revenue Up And Loss Narrows In Full Year

3 Oct 2019 10:41

Genedrive loss narrowed after double-digit revenue rise

(Sharecast News) - Genedrive on Thursday reported a narrowed annual loss as revenues jumped as its commercial relationship with the US department of defense (DoD) exceeded expectations.

9 Jul 2019 10:54

Genedrive Revenue To Suffer On Lower Uptake Of Hepatitis Test Kits

(Alliance News) - Shares in Genedrive PLC fell Tuesday after the company warned that it will miss market expectations for 2020 financial year revenue due to slower than expected uptake of the HCV

28 Mar 2019 10:36

Genedrive Interim Loss Narrows As It Continues Focus On Hepatitis

LONDON (Alliance News) - Genedrive PLC on Thursday reported a reduction in its interim loss, as it continues to progress its hepatitis testing product.For the six months to the end of 2018,

28 Mar 2019 07:59

Genedrive losses narrow despite increased R&D costs

(Sharecast News) - Molecular diagnostics company Genedrive saw revenues tick ahead slightly in the first half of its financial year but increased research and development costs kept the firm in the red.

Latest Share Chat

Genedrive Share News (GDR)

Share Price Information for Genedrive (GDR)

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK shareholder meetings calendar - next 7 days

Login to your account

Quickpicks are a member only feature

Login to your account